← Back to headlines
Kazia Therapeutics Reports Promising Clinical Results for Advanced Triple-Negative Breast Cancer Treatment
Initial trial data shows a 100% clinical benefit rate among six patients treated with the company's experimental therapy, offering early optimism for aggressive cancer subtypes.
27 Aug, 20:01 — 27 Aug, 20:01
